The immune system normally identifies and eliminates cancer cells prior to tumor formation. However, cancer cells can induce inhibitory mechanisms that limit antitumor immune activity, allowing for disease progression. In this webinar brought to you by The Scientist and Bio-Techne, Dario Vignali and Peter Westcott will discuss the tug-of-war between cancer cells and the immune system, how cancer cells evade immune cells, and what can be done to circumvent or attenuate these mechanisms for therapeutic purposes.
Topics to be covered
Understanding immune inhibitory mechanisms in cancer
Dario A. Vignali, PhD Frank Dixon Chair in Cancer Immunology Vice Chair and Distinguished Professor of Immunology Director, Cancer Immunology Training Program Department of Immunology, School of Medicine University of Pittsburgh
Peter Westcott, PhD Postdoctoral Scientist David H. Koch Institute for Integrative Cancer Research Massachusetts Institute of Technology
and we'll give you full access to the archived webinar when it becomes available!
Never miss an email from The Scientist. Click hereto add The Scientist to your safe-sender list.
The Scientist,1000 N West Street, Suite 1200, Wilmington, Delaware, United States, 19801 Toll-Free: (888) 781-0328 | Phone: (705) 528-6888 Email: privacy@the-scientist.com